Collagenous sprue (CS) is a distinct clinicopathological disorder histologically defined by a thickened subepithelial band (Freeman, 2011). It is a rare condition which has been recently observed in a significant proportion of sprue-like enteropathy associated with olmesartan, a novel entity described by Rubio-Tapia et al. in 2012. CS is historically associated with a poor prognosis (Marthey et al., 2014). However, histological and clinical improvements have been described in most studies with concomitant usage of corticosteroids and/or gluten-free diet (Marthey et al., 2014). We report a unique case of olmesartan-induced collagenous sprue in a 79-year-old man that showed complete histological and clinical remission with the sole withdrawal of the incriminating drug. The literature on this topic is briefly reviewed.
CITATION STYLE
Desruisseaux, C., Bensoussan, M., Désilets, E., Tran, H. K., Arcand, R., Poirier, G., … Manière, T. (2016). Adding Water to the Mill: Olmesartan-Induced Collagenous Sprue - A Case Report and Brief Literature Review. Canadian Journal of Gastroenterology and Hepatology. Hindawi Limited. https://doi.org/10.1155/2016/4837270
Mendeley helps you to discover research relevant for your work.